P
Peter Goldstraw
Researcher at National Institutes of Health
Publications - 231
Citations - 28207
Peter Goldstraw is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Lung cancer & Lung cancer staging. The author has an hindex of 68, co-authored 231 publications receiving 25178 citations. Previous affiliations of Peter Goldstraw include Harefield Hospital & National Health Service.
Papers
More filters
Journal ArticleDOI
Recurrent KRAS Codon 146 Mutations in Human Colorectal Cancer
Sarah Edkins,Sarah O’Meara,Adrian Parker,Claire Stevens,Marcelo Reis,Siân Jones,Christopher Greenman,Helen Davies,Gillian L. Dalgliesh,Simon A. Forbes,Christopher I. Hunter,Raffaella Smith,Philip J. Stephens,Peter Goldstraw,Andrew G. Nicholson,Tsun Leung Chan,Victor E. Velculescu,Siu Tsan Yuen,Suet Yi Leung,Michael R. Stratton,Michael R. Stratton,P. Andrew Futreal +21 more
TL;DR: Recurrent somatic missense mutations at alanine 146, a highly conserved residue in the guanine nucleotide binding domain, are identified, suggesting that the contribution of codon 146 mutations is not entirely restricted to colorectal cancers or to KRAS.
Journal ArticleDOI
Acute lung injury and acute respiratory distress syndrome after pulmonary resection
TL;DR: Patients that underwent pulmonary resection at the Royal Brompton Hospital between 1991 and 1997 were included and the case notes of all patients developing postoperative complications were retrospectively reviewed.
Journal ArticleDOI
Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimulated primary human lung alveolar type II epithelial cells and macrophages.
TL;DR: Activated alveolar epithelium is an important source of chemokines that orchestrate leukocyte migration to the peripheral lung; early release of TNF-α and IL-1β by stimulated macrophages may contribute to alveolars epithelial cell activation and chemokine production.
Journal ArticleDOI
High resolution computed tomography as a predictor of lung histology in systemic sclerosis
TL;DR: Assessment of the ability of high resolution computed tomography to predict the histological appearance of open lung biopsy specimens from patients with systemic sclerosis found a significant association between a fibrotic Histological appearance and a grade 4 computed tomogram, and between an inflammatory histological appearances and a level 3 computed tomograms.
Journal ArticleDOI
The IASLC Lung Cancer Staging Project: Methodology and Validation Used in the Development of Proposals for Revision of the Stage Classification of NSCLC in the Forthcoming (Eighth) Edition of the TNM Classification of Lung Cancer
Frank C. Detterbeck,Kari Chansky,Patti A. Groome,Vanessa Bolejack,John Crowley,Lynn Shemanski,Catherine Kennedy,Mark Krasnik,Michael D Peake,Ramón Rami-Porta,Peter Goldstraw,Hisao Asamura,David Ball,David G. Beer,Ricardo Beyruti,Frank C. Detterbeck,Wilfried Ernst Erich Eberhardt,John G. Edwards,Françoise Galateau-Sallé,Dorothy J. Giroux,Fergus V. Gleeson,James Huang,Jhingook Kim,Young Tae Kim,Laura Kingsbury,Haruhiko Kondo,Kaoru Kubota,Antoon Lerut,Gustavo Lyons,Mirella Marino,Edith M. Marom,Jan P. van Meerbeeck,Alan Mitchell,Takashi Nakano,Andrew G. Nicholson,Anna K. Nowak,Thomas W. Rice,Kenneth E. Rosenzweig,Enrico Ruffini,V. Rusch,Nagahiro Saijo,Paul Van Schil,Jean-Paul Sculier,Kelly L. Stratton,Kenji Suzuki,Yuji Tachimori,Charles F. Thomas,William D. Travis,Ming-Sound Tsao,Andrew T. Turrisi,Johan Vansteenkiste,Hirokazu Watanabe,Yi-Long Wu,Paul Baas,Jeremy J. Erasmus,Seiki Hasegawa,Kouki Inai,Kemp H. Kernstine,Hedy L. Kindler,Lee M. Krug,Kristiaan Nackaerts,Harvey I. Pass,David C. Rice,Conrad Falkson,Pier Luigi Filosso,Giuseppe Giaccone,Kazuya Kondo,Marco Lucchi,Meinoshin Okumura,Eugene H. Blackstone,F. Abad Cavaco,E. Ansótegui Barrera,J. Abal Arca,I. Parente Lamelas,A. Arnau Obrer,R. Guijarro Jorge,D. Ball,G.K. Bascom,A. I. Blanco Orozco,M. A. González Castro,M.G. Blum,D. Chimondeguy,V. Cvijanovic,S. Defranchi,B. de Olaiz Navarro,I. Escobar Campuzano,I. Macía Vidueira,E. Fernández Araujo,F. Andreo García,Kwun M. Fong,G. Francisco Corral,S. Cerezo González,J. Freixinet Gilart,L. García Arangüena,S. García Barajas,P. Girard,Tuncay Göksel,M. T. González Budiño,G. González Casaurrán,J. A. Gullón Blanco,J. Hernández Hernández,H. Hernández Rodríguez,J. Herrero Collantes,M. Iglesias Heras,J. M. Izquierdo Elena,Erik Jakobsen,S. Kostas,P. León Atance,A. Núñez Ares,M. Liao,M. Losanovscky,G. Lyons,R. Magaroles,L. De Esteban Júlvez,M. Mariñán Gorospe,Brian C. McCaughan,C. Kennedy,R. Melchor Íñiguez,L. Miravet Sorribes,S. Naranjo Gozalo,C. Álvarez de Arriba,M. Núñez Delgado,J. Padilla Alarcón,J. C. Peñalver Cuesta,Jongsun Park,M. J. Pavón Fernández,M. Rosenberg,Enrico Ruffini,V. Rusch,J. Sánchez de Cos Escuín,A. Saura Vinuesa,M. Serra Mitjans,Trond Eirik Strand,Dragan Subotic,S.G. Swisher,Ricardo Mingarini Terra,Charles R. Thomas,Kurt G. Tournoy,P. Van Schil,M. Velasquez,Y.L. Wu,K. Yokoi,Dorothy Giroux,William D. Travis,Marcin Zieliński,Wilfried Eberhardt,Jan van Meeerbeeck,Andrew G. Nicholson,Kouru Kubota,Alexander A. Bankier,Mary Beth Beasley,Douglas B. Flieder,Jin Mo Goo,Heber MacMahon,David P. Naidich,Charles A. Powell,Mathias Prokop,Yasushi Yatabe,Douglas A. Arenberg,Jessica S. Donington,Wilbur A. Franklin,Nicolas Girard,Peter J. Mazzone,Valerie W. Rusch,Lynn T. Tanoue +164 more
TL;DR: An extensive analysis has produced stage classification proposals for lung cancer with a robust degree of discriminatory consistency and general applicability and external validation is encouraged to identify areas of strength and weakness.